Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR114396A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 25-11-2020
Patent type: Formulations

Click within the document, or manually enter the page number below

CILFA opposition, pirfenidone , (AR112474A1)

Countries: Argentina Date: 2020
CILFA opposition, clodronic acid, (AR110319A1)

Countries: Argentina Date: 2019
CILFA opposition, mesalazine, (AR108231A1)

Countries: Argentina Date: 2018
CILFA opposition, estradiol, (AR107022A1)

Countries: Argentina Date: 2019
CILFA opposition, fenibrutinib, (AR107751A1)

Countries: Argentina Date: 2018
CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Countries: Argentina Date: 2002
CILFA opposition, amino acids, (AR110548A1)

Countries: Argentina Date: 2019
CILFA opposition, omega-3 polyunsaturated acids, (AR110450A1)

Countries: Argentina Date: 2019
CILFA opposition, estetrol/drospirenone, (AR114357A1)

Countries: Argentina Date: 2020
CILFA opposition, estetrol, (AR114799A1)

Countries: Argentina Date: 2020

Cilfa Opposition, Bempedoic Acid, (Ar114396 A1)